Published: 2017-01-10

Visual outcome of central serous retinopathy

Shanthi Latha Y J, Chevuturu Madhavi, M. Ashok Kumar


Background: Central serous chorioretinopathy (CSCR) is a sporadic disorder of the outer blood retinal barrier. Increasing evidence implicates an abnormal choroidal circulation as the cause of CSCR. The study aimed at the visual outcome of central serous retinopathy for a duration of 6 months from the primary attack.

Methods: Study conducted at Department of Ophthalmology in Out Patient Department of Mediciti Medical College Hospital, from June 2013 to December 2014. Total 30 patients’ eyes were treated with placebo treatment with antioxidants for a period of 6 months.

Results: Highest prevalence of central serous retinopathy was seen in age group of 20-40 years in 26 eyes (85%), males are predominant i.e. out of 30 patients 27 (90%), risk factors of central serous retinopathy like Type A personality are observed in 3. Associated visual abnormalities like micropsia, central scotomas in 20% of patients, fluorescein angiography showed 60% inkblot pattern. After observation for 6 months visual acuity was spontaneously improved within 4-6 months in 70% of patients, recurrences was seen in 6 patients i.e. 20% is observed.

Conclusions: Central serous retinopathy is most commonly seen among 20-40 years age group, with male predominance, unilateral in which Spontaneous resolution of central serous retinopathy is seen in 4-6 months so for which aggressive treatment is not necessary.



Central Serous Retinopathy, Unilateral, Fundus Fluorescein Angiography

Full Text:



Von Graefe A. Ueber centrale recidiverende retinitis. Graefes Arch Clin Exp Ophthalmol. 1866;12:211–5.

Klein BA. Macular lesions of vascular origin II. Functional vascular conditions leading to damage of the macula lutea. Am J Ophthalmol. 1953;36:1–13.

Maumenee. Serous and hemorrhagic disciform detachment of the macula. Trans Pacif Coast Oto-Ophthalmol Soc. 1959;40:139–60.

Maumenee AE. Discussion of Gass JDM. Pathogenesis of hemorrhagic disciform lesion of the posterior ocular fundus. A histopathologic study. Presented to Wilmer Annual Meeting, Baltimore, MD, 26 May 1964.

Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium. II. Idiopathic central choroiodopathy. Am J Ophthalmol. 1967;63:587–615.

Marmor MF. New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol. 1988;226:548-52.

Prante C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol. 1996;121:26-34.

Bennett G. Central serous retinopathy. Br J Ophthalmol. 1955;39:605-18.

Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996;103:2070-9.

Manjunath V, Fujimoto JG, Duker JS. Cirrus HD-OCT high definition imaging is another tool available for visualization of the choroid and provides agreement with the finding that the choroidal thickness is increased in central serous chorioretinopathy in comparison to normal eyes. Retina. 2010;30:1320-1.

Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol. 2009;148:445-50.

Hussain D, Gass JD. Idiopathic central serous chorioretinopathy. Indian J Ophthalmol. 1998;46:131-7.

Folk JC, Thompson HS, Han DP, Brown CK. Visual function abnormalities in central serous retinopathy. Arch Ophthalmol. 1984;102(9):1299-302.

Mutlak JA, Dutton GN, Zeini M, Allan D, Wail A. Central visual function in patients with resolved central serous retinopathy. A long term follow-up study. Acta Ophthalmol (Copenh). 1989;67:532–6.

Bujarborua D, et al. Long-term follow-up of idiopathic central serous chorioretinopathy without laser. Acta Ophthalmologica Scandinavica. 2001;79(4):417–21.

Simon AL, Borchert M. Etiology and prognosis of acute, late-onset esotropia. Ophthalmology. 1997;104:1348-52.